2Constantions D A, Ghada J C, Sotiris K H, et al. Synthesis and Characterization of (PTU) I2 and (CMBZT) I2 and Possible Implications for the Mechanism of Action of Anti- thyroid Drugs[J]. Eur J Inorg Chem, 2003, 1635-1640.
3Okabe O, Fujiwara T, Yamagata Y, et al. Structure of a potent Anti-thyroid Drug , 6-Prooyl-2-thiouracil[J]. B Chem Soc Jpn, 1983, 56: 1543-1544.
4Rownicka Z, Sulkowska A, Bojkoet B,et al. Binding of 6- propyl-2-thiouraeil to human serum albumin destabilized by chemical denaturants I J]. J Photo Ch Photo Bio, 2009, 97: 54-59.
5Meng G, Chen F E, Erik D C, et al. Nonnucleo side HIV-1 Reverse Transcriptase Inhibitors: Part I. Synthesis and Structure-Activity Relationship of 1-Alkoxymethy1-5- alkyl-6-naphthylmethyluracils as HEPT Analogues [J]. Chem Pharm bull, 2003, 51(7): 779-789.
7Pankovic Z, Jennifer K, Jennifer K, et al. Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin[J].Bio org Med Chem Lett, 2010, 20: 1524-1527.
8Ismail M A H, Abozid KA M, A1-Ansary G H A, et al. Computer based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2" -earbethoxy -biphenylylmethyl moieties as otl-adrenoceptor antagonists and angiotensin II.AT1 receptor antagonists[J]. Die Pharmazie, 2010, 65(11): 794-800.